PPLPHARMA Q4 FY25 Results & Concall Summary: Key Takeaways (PPLPHARMA)

PPLPHARMA Q4 FY25 (Mar-2025 Qtr) Earnings call highlights: Key takeaways, performance, financial metrics, outlook and guidance, concerns and management tone.

Piramal Pharma Ltd (PPLPHARMA) Q4FY25 Concall Summary - Mar-2025 Qtr

The concall summary for this quarter is not available yet.